InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the complete record of transactions filed by Spear Matthew A., Directeur Médical. Director active across 1 company, notably Poseida Therapeutics, Inc.. In total, 13 reports have been recorded. History available since 11 June 2021. The latest transaction was disclosed on 1 March 2022 (Attribution). Regulator: SEC (Form 4). All data is free.
Declarations13 total
50,000 shares0Common StockSEC:0001209191-22-014373:0
10,000 shares@ US$1.3229.8% of flowCommon StockSEC:0001209191-21-068629
10,000 shares@ US$1.3229.8% of flowCommon StockSEC:0001209191-21-068629:0
10,000 shares@ US$1.3229.4% of flowCommon StockSEC:0001209191-21-055443:0
10,000 shares@ US$1.3229.4% of flowCommon StockSEC:0001209191-21-055443
4,000 shares@ US$1.3223.8% of flowCommon StockSEC:0001209191-21-053177:0
4,000 shares@ US$1.3223.8% of flowCommon StockSEC:0001209191-21-053177
20,000 shares@ US$1.32218.7% of flowCommon StockSEC:0001209191-21-048793
20,000 shares@ US$1.32218.7% of flowCommon StockSEC:0001209191-21-048793:0
5,000 shares@ US$1.3224.7% of flowCommon StockSEC:0001209191-21-042292
5,000 shares@ US$1.3224.7% of flowCommon StockSEC:0001209191-21-042292:0
4,000 shares@ US$1.3223.6% of flowCommon StockSEC:0001209191-21-040324
4,000 shares@ US$1.3223.6% of flowCommon StockSEC:0001209191-21-040324:0
13 of 13 declarations
About Spear Matthew A.
Matthew A. Spear is the Chief Medical Officer at Poseida Therapeutics, Inc. He is responsible for the medical direction of the company, overseeing clinical research and the development of new treatments. His role is essential in ensuring innovation and safety of Poseida's products.
